Pursuant to Regulation 34(1) of the SEBI (LODR) Regulations, 2015, we are enclosing herewith the Annual Report for the financial year 2024-25.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Veerhealth Care Ltd has filed its 33rd Annual Report for FY 2024-25 with BSE, along with the notice for its Annual General Meeting scheduled for September 30, 2025. Revenue from operations grew to Rs. 1,667.05 lakhs from Rs. 1,322.31 lakhs in FY23-24, a rise of about 26%. However, profit after tax slipped slightly to Rs. 39.14 lakhs from Rs. 40.61 lakhs, while pre-tax profit fell sharply to Rs. 50.78 lakhs from Rs. 128.14 lakhs, mainly due to higher depreciation and finance costs. The board has skipped dividend to fund expansion. AGM items include appointment of M/s. Nidhi Shah & Associates as Secretarial Auditor for five years (FY25-26 to FY29-30) and continuation of Mr. Prakashbhai C. Shah as Independent Director beyond age 75.
Revenue growth is positive, but the sharp drop in pre-tax profit and continued absence of dividend suggest margin pressure. Shareholders should review the AGM items, especially the new Secretarial Auditor appointment and the continuation of an independent director past 75 years. No immediate price catalyst, but expansion plans in ayurvedic and e-commerce products could drive future growth.